4.7 Article

Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril/valsartan treatment

Ying-Hsiang Lee et al.

Summary: This study compares the left ventricular ejection fraction (LVEF) improvement and its association with clinical outcomes in patients with different etiologies following sacubitril/valsartan (SAC/VAL) treatment. The results show that patients with non-ischaemic cardiomyopathy (NICM) have a higher degree of LVEF improvement compared to those with ischaemic cardiomyopathy (ICM), and significant improvement in LVEF in NICM patients is associated with favorable clinical outcomes.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)

Article Cardiac & Cardiovascular Systems

Epidemiology of Heart Failure A Contemporary Perspective

Veronique L. Roger

Summary: This review summarizes recent studies on the epidemiology of heart failure (HF) over the past decade, indicating that while the incidence of HF is mostly flat or declining, the burden of mortality and hospitalization remains significant, especially with major disparities among younger Black men and women. Emerging risk factors and holistic management approaches may help improve the treatment and management of HF.

CIRCULATION RESEARCH (2021)

Article Medicine, General & Internal

Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy

Mohammad Abumayyaleh et al.

Summary: This study shows that ARNI treatment can improve LVEF in both ICMP and NICMP patients, but the risk of ventricular tachyarrhythmias remains higher in the ICMP group. Patients with NICMP experienced improvement in renal function after treatment, with similar long-term mortality rates in both groups over a one-year follow-up.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Pharmacology & Pharmacy

Combination pharmacotherapies for cardiac reverse remodeling in heart failure patients with reduced ejection fraction: A systematic review and network meta-analysis of randomized clinical trials

Jieli Bao et al.

Summary: Pharmacotherapies, including ACEIs, ARBs, BBs, MRAs, and ARNI, have shown to be pivotal in reducing in-hospital and mortality in HFrEF patients. Combination therapies have demonstrated more benefits on CRR, with ARNI+BB, ARB+BB, ARNI+BB+MRA, and ARB+BB+MRA being the top two effective dual and triple combinations in LVEF improvement, while the new Golden Triangle of ARNI+BB+MRA outperformed ACEI+BB+MRA or ARB+BB+MRA in LVEF improvement.

PHARMACOLOGICAL RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Theresa A. McDonagh et al.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study

Upasana Tayal et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Letter Cardiac & Cardiovascular Systems

Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan

James L. Januzzi et al.

CIRCULATION-HEART FAILURE (2020)

Letter Cardiac & Cardiovascular Systems

The PARAGON-HF Trial Toward Extension to Patients With HF Middle Range Ejection Fraction

Edoardo Gronda et al.

JACC-HEART FAILURE (2020)

Letter Cardiac & Cardiovascular Systems

Sacubitril/Valsartan, Cardiac Fibrosis, and Remodeling in Heart Failure

Alberto Aimo et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF

Craig Balmforth et al.

JACC-HEART FAILURE (2019)

Article Cardiac & Cardiovascular Systems

Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial

Scott D. Solomon et al.

CIRCULATION-HEART FAILURE (2018)

Article Cardiac & Cardiovascular Systems

Assessing observer variability: a user's guide

Zoran B. Popovic et al.

CARDIOVASCULAR DIAGNOSIS AND THERAPY (2017)

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure

John J. V. McMurray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Cardiac & Cardiovascular Systems

Clinical epidemiology of heart failure

Arend Mosterd et al.

HEART (2007)

Article Cardiac & Cardiovascular Systems

Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure

Jesper Kjaergaard et al.

EUROPEAN JOURNAL OF HEART FAILURE (2007)